Fig. 4

Simon and Makuch’s modified Kaplan–Meier curves for overall survival (A) and progression-free survival (B) in colorectal cancer patients who received a combination of trifluridine-tipiracil and bevacizumab. Data were statistically compared by time-varying Cox regression adjusting for age and modified Glasgow prognostic score (mGPS)